PharmiWeb.com - Global Pharma News & Resources
21-Jun-2019

Molecular Diagnostics Market At A Vigorous CAGR Of 11% With Likely To Generate Of 15.6 Billion USD By 2024

Global Molecular Diagnostics Market was valued at USD 7.5 billion in 2017 and is likely to generate a demand of USD 15.6 billion by 2024, at a vigorous CAGR of 11% over the forecast period.

The global molecular diagnostics Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2018 to 2024. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2018 to 2024.

We can provide sample pages for a better understanding of this report.
Request Sample of This Report @ http://www.amecoresearch.com/sample/11461

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the global molecular diagnostics market.

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market.

The market is studied for regions such as North America (U.S., and Canada), Europe (U.K., Germany, France, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East amp; Africa (GCC, South Africa, and Rest of Middle East amp; Africa).

Key Takeaways:

What is the market size in 2018 and the growth rate of the global molecular diagnostics market?

What is the market drivers, restrains, opportunities governing the global molecular diagnostics Market?

Which are the largest and the fastest growing segments in the global molecular diagnostics market?

Who are the key players operating in the market and their market position?

What is the pipeline scenario, drug pricing analysis and technological development in the market?

View Detail Report With Complete Table Of Content@ http://www.amecoresearch.com/market-report/global-molecular-diagnostics-market-emr-11461

The growth in the market is attributed to the growing number of infectious diseases and chronic diseases across the globe, improving reimbursement scenario, and increasing adoption of advanced diagnostic techniques. Moreover, the growing increase in collaborative diagnostic programs and increasing investments in diagnostic healthcare is further propelling the industry growth. The years used for the assessment are as follows:

Historical year: 2014, 2015 and 2016

Base year: 2017

Forecast period: 2018 ndash; 2024

RESEARCH METHODOLOGY

The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;

Obtaining historical data of the market based on news, articles, publications, annual reports, white papers, surveys, and other secondary sources
Interacting with key opinion leaders of the market and developing data points based on interaction with them
Study of past trends in the market and their year on year Impact on the market size and share
Analyzing the collected data points
Bridging the data points to calculate the total global molecular diagnostics market and its various segments
Anticipating potential risks
Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global molecular diagnostics market
Finalizing the overall size and share of the global molecular diagnostics market

OBJECTIVES:

To analyze market trends, opportunities, drivers, and restraints associated with the global molecular diagnostics market
To study market response with respect to the mergers and acquisitions in the industry
To profile key companies operating in the global molecular diagnostics market and provide their competitive landscape

MARKET SCOPE

The research scope for global molecular diagnostics market is as follows:

Product and Service

Instruments
Reagents and Kits
Services and Software

Technology

DNA Sequencing and Next-Generation Sequencing (NGS)
DNA Microarray
Fluorescent in Situ Hybridization
Nucleic Acid Amplification (NAT)
Polymerase Chain Reaction (PCR)
Other

Application

Infectious Disease
Virology
HIV viral load
HCV viral load
HBV viral load
CMV viral load
HPV
HSV
EBV
influenza A/B
others
Bacteriology
Chlamydia
Gonorrhea
pertussis
Methicillin-resistant Staphylococcus aureus (MRSA)
CT/NG
Healthcare Acquired Infections (HAIs)
Genomics Testing
Inherited Disorders
Human Leukocyte Antigen(HLA) testing
Pharmacogenetics
Blood Donor Screening
Oncology
Colorectal cancer
Pancreatic cancer
Brain cancer
Kidney cancer
Thyroid cancer
Breast cancer
Lung cancer
Melanoma
Prostate cancer
Precancer
Leukemia
Lymphoma
Bladder cancer
Cervical cancer
Chest cancer

End-user

Laboratories
Hospitals
Other

By Region

North America
Europe
Asia-Pacific
Central amp; South America
Middle East and Africa (MEA)

FREE ANALYSIS

Molecular diagnostics play an important role in understanding the pathogenesis of various diseases, as well as in their diagnosis and treatment. The healthcare system is critically and crucially dependent upon diagnostics. Molecular diagnostics has transformed diagnosis dynamically by providing insights into the treatment of various diseases. Molecular diagnostics market represents a relatively new era in medicine that offers benefits of detecting diseases at an early stage. The major factors driving the growth are increasing incidences of chronic diseases, and the ongoing fight against cancer and other illnesses.

Geographically, North America held the largest share of the market in 2017. The growth in the region is attributed to the increasing elderly population, rising incidence of chronic diseases, and growing development in pharmacogenomics. Moreover, the growing demand for infectious disease testing and the presence of major player in the region is further boosting the market growth. Asia-Pacific is expected to witness the highest CAGR during the forecast period, owing to growing investment in the healthcare diagnostics, and increasing adoption of molecular diagnostics test.

Some of the key companies operating in the market include QIAGEN , HTG Molecular Diagnostics, Inc., Abbott Laboratories , bioMeacute;rieux SA, Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd), Becton, Dickinson and Company, Hologic Inc., Cepheid, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., and Genetic Signatures Ltd among others.

Few Significant from Table Of Contents

Global Molecular Diagnostics Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation amp; Forecast 2024

CHAPTER 1. Market Scope and Methodology

1.1. Research methodology
1.2. Research scope amp; assumptions
1.3. List of data sources

CHAPTER 2. Executive Summary

2.1. Molecular Diagnostics- Market Snapshot

CHAPTER 3. Industry Analysis

3.1. Market definition
3.2. Market segmentation
3.3. Key findings of the global molecular diagnostics market
3.4. Value chain analysis
3.5. Market opportunities amp; trends
3.5.1. Increasing investments in diagnostic healthcare
3.5.2. Growing research and development activities in molecular testing
3.6. Market driver analysis
3.6.1. Increase in collaborative diagnostic programs
3.6.2. Growing demand for genetic and genomic information
3.6.3. Increasing adoption of advanced diagnostic techniques
3.6.4. Improving reimbursement scenario
3.7. Market restraint analysis
3.7.1. High cost of molecular diagnostic tests
3.7.2. Stringent regulatory norms associated with molecular diagnostic test

CHAPTER 4. Competitive Outlook

4.1. Competitive analysis
4.1.1. Industry Analysis-Porters five forces analysis
4.1.2. Company Share Analysis
4.2. Competitive factors

CHAPTER 5. Global Molecular Diagnostics Market Size and Forecast (2014 ndash; 2024)

5.1. Global Molecular Diagnostics Market, By Product and Service
5.1.1. Instruments
5.1.2. Reagents and Kits
5.1.3. Services and Software
5.2. Global Molecular Diagnostics Market, By Technology
5.2.1. DNA Sequencing amp; Next-Generation Sequencing (NGS)
5.2.2. DNA Microarray
5.2.3. Fluorescent in Situ Hybridization
5.2.4. Nucleic Acid Amplification (NAT)
5.2.5. Polymerase Chain Reaction (PCR)
5.2.6. Other
5.3. Global Molecular Diagnostics Market, By Application
5.3.1. Infectious Disease
5.3.1.1. Virology
5.3.1.1.1. HIV viral load
5.3.1.1.2. HCV viral load
5.3.1.1.3. HBV viral load
5.3.1.1.4. CMV viral load
5.3.1.1.5. HPV
5.3.1.1.6. HSV
5.3.1.1.7. EBV
5.3.1.1.8. Influenza A/B
5.3.1.1.9. Others
5.3.1.2. Bacteriology
5.3.1.2.1. Chlamydia
5.3.1.2.2. Gonorrhea
5.3.1.2.3. B. pertussis
5.3.1.2.4. Methicillin-resistant Staphylococcus aureus (MRSA)
5.3.1.2.5. CT/NG
5.3.1.2.6. Healthcare Acquired Infections (HAIs)
5.3.2. Genomics Testing
5.3.2.1. Inherited Disorders
5.3.2.2. Human Leukocyte Antigen(HLA) testing
5.3.2.3. Pharmacogenetics
5.3.3. Oncology
5.3.3.1. Colorectal cancer
5.3.3.2. Pancreatic cancer
5.3.3.3. Brain cancer
5.3.3.4. Kidney cancer
5.3.3.5. Thyroid cancer
5.3.3.6. Breast cancer
5.3.3.7. Lung cancer
5.3.3.8. Melanoma
5.3.3.9. Prostate cancer
5.3.3.10. Precancer
5.3.3.11. Leukemia
5.3.3.12. Lymphoma
5.3.3.13. Bladder cancer
5.3.3.14. Cervical cancer
5.3.3.15. Chest cancer
5.3.4. Blood Donor Screening
5.4. Global Molecular Diagnostics Market, By End-user
5.4.1. Laboratories
5.4.2. Hospitals
5.4.3. Other

CHAPTER 6. Global Molecular Diagnostics Market, By Geography

6.1. North America Molecular Diagnostics Market
6.1.1. North America Molecular Diagnostics Market, By Product and Service (USD Billion)
6.1.2. North America Molecular Diagnostics Market, By Technology (USD Billion)
6.1.3. North America Molecular Diagnostics Market, By Application (USD Billion)
6.1.4. North America Molecular Diagnostics Market, By End-user (USD Billion)
6.1.5. North America Molecular Diagnostics Market, By Country
6.1.5.1. U.S.
6.1.5.2. Canada
6.1.5.3. Mexico
6.2. Europe Molecular Diagnostics Market
6.2.1. Europe Molecular Diagnostics Market, By Product and Service (USD Billion)
6.2.2. Europe Molecular Diagnostics Market, By Technology (USD Billion)
6.2.3. Europe Molecular Diagnostics Market, By Application (USD Billion)
6.2.4. Europe Molecular Diagnostics Market, By End-user (USD Billion)
6.2.5. Europe Molecular Diagnostics Market, By Country
6.2.5.1. Spain
6.2.5.2. UK
6.2.5.3. Netherlands
6.2.5.4. Germany
6.2.5.5. Italy
6.2.5.6. Spain
6.2.5.7. France
6.2.5.8. Rest of Europe
6.3. Asia-Pacific Molecular Diagnostics Market
6.3.1. Asia-Pacific Molecular Diagnostics Market, By Product and Service (USD Billion)
6.3.2. Asia-Pacific Molecular Diagnostics Market, By Technology (USD Billion)
6.3.3. Asia-Pacific Molecular Diagnostics Market, By Application (USD Billion)
6.3.4. Asia-Pacific Molecular Diagnostics Market, By End-user (USD Billion)
6.3.5. Asia-Pacific Molecular Diagnostics Market, By Country
6.3.5.1. China
6.3.5.2. Australia
6.3.5.3. Japan
6.3.5.4. Singapore
6.3.5.5. South Korea
6.3.5.6. India
6.3.5.7. Rest of Asia-Pacific
6.4. Centeral and South America Molecular Diagnostics Market
6.4.1. Centeral and South America Molecular Diagnostics Market, By Product and Service (USD Billion)
6.4.2. Centeral and South America Molecular Diagnostics Market, By Technology (USD Billion)
6.4.3. Centeral and South America Molecular Diagnostics Market, By Application (USD Billion)
6.4.4. Centeral and South America Molecular Diagnostics Market, By End-user (USD Billion)
6.4.5. Centeral and South America Molecular Diagnostics Market, By Country
6.4.5.1. Brazil
6.4.5.2. Rest of Central and South America
6.5. Middle East and Africa Molecular Diagnostics Market
6.5.1. Middle East and Africa Molecular Diagnostics Market, By Product and Service (USD Billion)
6.5.2. Middle East and Africa Molecular Diagnostics Market, By Technology (USD Billion)
6.5.3. Middle East and Africa Molecular Diagnostics Market, By Application (USD Billion)
6.5.4. Middle East and Africa Molecular Diagnostics Market, By End-user (USD Billion)
6.5.5. Middle East and Africa Molecular Diagnostics Market, By Country
6.5.5.1. South Africa
6.5.5.2. Saudi Arabia
6.5.5.3. Rest of Middle East and Africa

CHAPTER 7. Key Players and Strategic Developments

7.1. QIAGEN
7.1.1. Business Overview
7.1.2. Product and Service Offering
7.1.3. Financial Overview
7.1.4. Strategic Developments
7.2. HTG Molecular Diagnostics, Inc.
7.2.1. Business Overview
7.2.2. Product and Service Offering
7.2.3. Financial Overview
7.2.4. Strategic Developments
7.3. Abbott Laboratories
7.3.1. Business Overview
7.3.2. Product and Service Offering
7.3.3. Financial Overview
7.3.4. Strategic Developments
7.4. bioMeacute;rieux SA
7.4.1. Business Overview
7.4.2. Product and Service Offering
7.4.3. Financial Overview
7.4.4. Strategic Developments
7.5. Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd)
7.5.1. Business Overview
7.5.2. Product and Service Offering
7.5.3. Financial Overview
7.5.4. Strategic Developments
7.6. Becton, Dickinson and Company
7.6.1. Business Overview
7.6.2. Product and Service Offering
7.6.3. Financial Overview
7.6.4. Strategic Developments
7.7. Hologic Inc.
7.7.1. Business Overview
7.7.2. Product and Service Offering
7.7.3. Financial Overview
7.7.4. Strategic Developments
7.8. Cepheid
7.8.1. Business Overview
7.8.2. Product and Service Offering
7.8.3. Financial Overview
7.8.4. Strategic Developments
7.9. Siemens Healthcare GmbH
7.9.1. Business Overview
7.9.2. Product and Service Offering
7.9.3. Financial Overview
7.9.4. Strategic Developments
7.10. Thermo Fisher Scientific Inc.
7.10.1. Business Overview
7.10.2. Product and Service Offering
7.10.3. Financial Overview
7.10.4. Strategic Developments
7.11. Genetic Signatures Ltd
7.11.1. Business Overview
7.11.2. Product and Service Offering
7.11.3. Financial Overview
7.11.4. Strategic Developments

Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/11461

About Us:

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making a purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact:

Email: sales@amecoresearch.com | +1 407 915 4157

Editor Details

Last Updated: 21-Jun-2019